What this means
The FDA approved a cheaper copy of a weekly hormone patch called Climara Pro. This news only says the patch was approved, not how well it works.
Plain-English summary written by an AI model from the announcement.
The original
- Headline
- FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
- From
- FDA press announcement
- Published
- Oct 20, 2026
Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week.